Kincell Bio published a Quality Minute featuring Chief Quality Officer Melodie Bryce discussing the role of Quality in programs.

Public source

Publisher name

Public post

Does Quality slow things down? Or can it actually help programs move faster? In our latest Quality Minute, Melodie Bryce, Chief Quality Officer at Kincell Bio, challenge…

Log in to read the full post

Company

Kincell Bio

Your CDMO Partner from Clinical to Commercial

Industry
Pharmaceutical Manufacturing
Location
Durham, US
Company size
51–200 employees

About Kincell Bio

Tomorrow’s Cures. Developed. Delivered. Kincell Bio is a specialized cell therapy CDMO dedicated exclusively to advancing autologous and allogeneic cell therapies from early development through commercialization and commercial manufacturing. We partner closely with innovators to streamline CMC strategies, integrate process and analytical development, and deliver reliable, GMP-compliant manufacturing. Guided by our core pillars, Quality First, Better Science, Reliable Supply, Personalized Service, and Right Scale, we operate as an extension of our clients’ teams. With facilities in Gainesville, FL, and Research Triangle Park, NC, our dedicated experts support process development, assay optimization, clinical and pivotal manufacturing, and inspection readiness. At Kincell Bio, quality is embedded by design, enabling us to de-risk development, accelerate timelines, and help bring tomorrow’s cures to patients with confidence.

See more

Latest activity

9 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.